Interactions between cationic liposomes and drugs or biomolecules.
Multiple uses for synthetic cationic liposomes composed of dioctadecyldimethylammonium bromide (DODAB) bilayer vesicles are presented. Drugs or biomolecules can be solubilized or incorporated in the cationic bilayers. The cationic liposomes themselves can act as antimicrobial agents causing death of bacteria and fungi at concentrations that barely affect mammalian cells in culture. Silica particles or polystyrene microspheres can be functionalized by coverage with DODAB bilayers or phospholipid monolayers. Negatively charged antigenic proteins can be carried by the cationic liposomes which generate a remarkable immunoadjuvant action. Nucleotides or DNA can be physically adsorbed to the cationic liposomes to be transferred to mammalian cells for gene therapy. An overview of the interactions between DODAB vesicles and some biomolecules or drugs clearly points out their versatility for useful applications in a near future.
Carmona-Ribeiro
A M
AM
Departamento de Bioquímica, Universidade de São Paulo, Brazil. mcribeir@quim.iq.usp.br
D000900:Anti-Bacterial Agents / Q000737:chemistry*; D004337:Drug Carriers; D004347:Drug Interactions; D004926:Escherichia coli / Q000187:drug effects; D008081:Liposomes / Q000737:chemistry*; D000644:Quaternary Ammonium Compounds / Q000737:chemistry*; D013501:Surface-Active Agents / Q000737:chemistry*
D000900:Anti-Bacterial Agents; D004337:Drug Carriers; D008081:Liposomes; D000644:Quaternary Ammonium Compounds; D013501:Surface-Active Agents; C015831:dimethyldioctadecylammonium